This week, the patent office published 1,383 applications along with 993 patent grants. The design office registered a total of 509 designs. Continue Reading Weekly Patent and Industrial Design Statistics – 27th January 2023 to 3rd February 2023
This week, the patent office published 1,100 applications along with 818 patent grants. The design office registered a total of 1,194 designs. Continue Reading Weekly Patent and Industrial Design Statistics – 20th January 2023 to 27th January 2023
The 2nd issue of the Patent Journal, 2023 has published 1,124 patent applications, with 689 of these being early publications and 435 classified as ordinary publications. Compared to the preceding week, this week‘s total grants have decreased by 6.53% to 916 applications. Continue Reading Weekly Patent and Industrial Design Statistics – 6th January 2023 to 13th January 2023
Learn about the patent cliff and how Novartis’ heart failure drug Vymada (Entresto®) will expire its patent protection in 2023. Find out more about secondary patents that can extend market exclusivity of Entresto® until 2033. Continue Reading Profiting from the Patent Cliff: What Drug Manufacturers Need to Know about Secondary Patents
The question of whether Artificial Intelligence (AI) can be an inventor in a patent application has been the subject of debate for a while now. There are arguments for and against this issue, and a few models have been proposed to resolve some of the legal problems. Read more Continue Reading Patent Application Naming AI as Inventor in India – Dr. Kalyan C. Kankanala opposes Stephen Thaler’s Patent application
A patent attorney can help companies to protect their inventions and to commercialise their technology. They can provide advice on the patentability of an invention, on the drafting of patent applications, and on infringement and validity issues. In addition, they can offer other services, such as freedom-to-operate opinions, due diligence reports, and patent portfolio management. Read More Continue Reading What are the Benefits of working with a Patent Attorney?
Justice Pratibha Singh clarifies the jurisdiction of High Courts over Patent Revocations and Appeals
Over the last two years, the orders of Justice Pratibha Singh have clarified several aspects of patent law and practice, and have made important contributions to transparency and consistency of patent proceedings. On November 10, 2022, Justice Pratibha Singh clarified one ambiguous aspect of patent law with respect to the jurisdiction of High Courts in different proceedings. Read More Continue Reading Justice Pratibha Singh clarifies the jurisdiction of High Courts over Patent Revocations and Appeals
Boehringer Ingelheim International GMBH vs The Controller Of Patents & Anr. on 12 July, 2022
Delhi High Court
Facts / Background
The Applicant, Boehringer Ingelheim International GMBH, had filed a National Phase PCT Application on 14th November, 2008, for 'Use of IV Inhibitors'. The patent specification had Claims numbered 1 - 18, with two claims numbered as 15, which were referred to as 15 and 15A.
The First Examination Report ("FER") was issued on 24th March, 2014, in response to…
Introduction
Have you ever watched episodes of the show ‘The Big Bang Theory’ wherein Sheldon, Leonard and Howard were contracted to devise a solution for the military? Such scenarios occur on a daily basis. The military, through its Defence Research and Development Organisation (hereinafter ‘DRDO’) contract or sub-contract researchers to innovate for and comply with their set standards and requirements. The result of these agreements are technological advancements that benefit the Defence Research and Development Organisation and thereby benefit the…
This running post provides a summary of the latest patent cases decided by courts in India in 2022:
MSN Laboratories Pvt. Ltd v. Novartis Ag.
The present suit was an appeal filed before the High Court of Telangana against an ad interim injunction order passed by the City Civil Court, Hyderabad. The lower court held that the Novartis Ag had established prima facie case of infringement against MSN Laboratories Private Limited. Novartis Ag filed the suit concerning a novel and inventive…